C-aryl glucoside SGLT2 inhibitors and method
US7589193B2 · kind B2 · utility
42Cited by
51References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 23, 2005 |
| Grant date | Sep 15, 2009 |
| Priority date | — |
| Expiry date | Nov 30, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H15/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of the formula IA method is also provided for treating diabetes and related diseases employing the above compound alone or in combination with another therapeutic agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.